Involvement of free radicals and oxidative stress in NAFLD/NASH

Abstract Non-alcoholic fatty liver disease (NAFLD) is now the most common liver disease affecting high proportion of the population worldwide. NAFLD encompasses a large spectrum of conditions ranging from fatty liver to non-alcoholic steatohepatitis (NASH), which can progress to cirrhosis and cancer. NAFLD is considered as a multifactorial disease in relation to the pathogenic mechanisms. Oxidative stress has been implicated in the pathogenesis of NAFLD and NASH and the involvement of reactive oxygen species (ROS) has been suggested. Many studies show the association between the levels of lipid oxidation products and disease state. However, often neither oxidative stress nor ROS has been characterized, despite oxidative stress is mediated by multiple active species by different mechanisms and the same lipid oxidation products are produced by different active species. Further, the effects of various antioxidants have been assessed in human and animal studies, but the effects of drugs are determined by the type of active species, suggesting the importance of characterizing the active species involved. This review article is focused on the role of free radicals and free radical-mediated lipid peroxidation in the pathogenesis of NAFLD and NASH, taking characteristic features of free radical-mediated oxidation into consideration. The detailed analysis of lipid oxidation products shows the involvement of free radicals in the pathogenesis of NAFLD and NASH. Potential beneficial effects of antioxidants such as vitamin E are discussed.

[1]  E. Niki Biomarkers of lipid peroxidation in clinical material. , 2014, Biochimica et biophysica acta.

[2]  E. Niki Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. , 2014, Free radical biology & medicine.

[3]  H. Guillou,et al.  The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. , 2013, Biochemical pharmacology.

[4]  M. Speechley,et al.  Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver disease , 2013, Alimentary pharmacology & therapeutics.

[5]  C. Kiyose,et al.  Effects of tocotrienol on tumor necrosis factor-α/d-galactosamine-induced steatohepatitis in rats , 2013, Journal of clinical biochemistry and nutrition.

[6]  N. Nieto,et al.  CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. , 2013, Journal of hepatology.

[7]  T. Ikeda,et al.  Dysregulated expression of fatty acid oxidation enzymes and iron‐regulatory genes in livers of Nrf2‐null mice , 2012, Journal of gastroenterology and hepatology.

[8]  A. Sanyal,et al.  Vitamin E and nonalcoholic fatty liver disease , 2012, Current opinion in clinical nutrition and metabolic care.

[9]  C. Pignata,et al.  Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions , 2012, Italian Journal of Pediatrics.

[10]  S. Hazen,et al.  Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism , 2012, Hepatology.

[11]  K. Safranow,et al.  Lipidic last breath of life in patients with alcoholic liver disease. , 2012, Prostaglandins & other lipid mediators.

[12]  A. Sanyal,et al.  Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH) , 2012, PloS one.

[13]  J. Manautou,et al.  Nrf2: A Potential Target for New Therapeutics in Liver Disease , 2012, Clinical pharmacology and therapeutics.

[14]  S. Fargion,et al.  Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. , 2012, World journal of gastroenterology.

[15]  A. Wierzbicki,et al.  Nonalcoholic fatty liver disease and lipids , 2012, Current opinion in lipidology.

[16]  K. Cusi,et al.  Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[17]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[18]  T. Miyazaki,et al.  Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease , 2012, Journal of Gastroenterology.

[19]  E. Niki,et al.  Fatty liver induced by free radicals and lipid peroxidation , 2012, Free radical research.

[20]  C. Lawton,et al.  Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2012 .

[21]  C. Palmeira,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free Radical Biology & Medicine.

[22]  A. Feldstein,et al.  Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo‐controlled trial , 2011, Hepatology.

[23]  Jianqiang Guo,et al.  Upregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitis. , 2011, Hepato-gastroenterology.

[24]  J. Crowley,et al.  Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial ( SELECT ) , 2011 .

[25]  L. N. Valenti,et al.  Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. , 2011, Journal of hepatology.

[26]  B. Fromenty,et al.  Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. , 2011, Clinics and research in hepatology and gastroenterology.

[27]  L. Iuliano Pathways of cholesterol oxidation via non-enzymatic mechanisms. , 2011, Chemistry and physics of lipids.

[28]  H. Yin,et al.  Free radical lipid peroxidation: mechanisms and analysis. , 2011, Chemical reviews.

[29]  A. Bast,et al.  The role of oxidative stress in non-alcoholic steatohepatitis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[30]  R. Green,et al.  Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. , 2011, Annals of hepatology.

[31]  Guolin Li,et al.  Plasma reactive carbonyl species levels and risk of non‐alcoholic fatty liver disease , 2011, Journal of gastroenterology and hepatology.

[32]  V. de Lédinghen,et al.  A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. , 2011, Journal of hepatology.

[33]  P. Rosenthal,et al.  Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. , 2011, JAMA.

[34]  D. Häussinger,et al.  Plasma levels of vitamin E and carotenoids are decreased in patients with nonalcoholic steatohepatitis (NASH) , 2011, European journal of medical research.

[35]  M. Davies Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention , 2010, Journal of clinical biochemistry and nutrition.

[36]  P. Kochanek,et al.  Mass‐spectrometry based oxidative lipidomics and lipid imaging: applications in traumatic brain injury , 2010, Journal of neurochemistry.

[37]  R. Bruno,et al.  Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis. , 2010, The Journal of nutritional biochemistry.

[38]  April D. Lake,et al.  Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease , 2010, Drug Metabolism and Disposition.

[39]  K. Itoh,et al.  Discovery of the negative regulator of Nrf2, Keap1: a historical overview. , 2010, Antioxidants & redox signaling.

[40]  S. Hazen,et al.  Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.

[41]  E. Niki Assessment of antioxidant capacity in vitro and in vivo. , 2010, Free radical biology & medicine.

[42]  T. Berg,et al.  High‐dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double‐blind, randomized, placebo‐controlled trial , 2010, Hepatology.

[43]  F. Galvano,et al.  l-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis—A Randomized and Controlled Clinical Trial , 2010, The American Journal of Gastroenterology.

[44]  B. Neuschwander‐Tetri,et al.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.

[45]  W. Schunck,et al.  Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids , 2010 .

[46]  M. Khoshbaten,et al.  N-Acetylcysteine Improves Liver Function in Patients with Non-Alcoholic Fatty Liver Disease , 2010, Hepatitis monthly.

[47]  J. Hayes,et al.  Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. , 2010, Free radical biology & medicine.

[48]  Hirokazu Takahashi,et al.  The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease , 2010, Journal of Gastroenterology.

[49]  Michelle M Wiest,et al.  The plasma lipidomic signature of nonalcoholic steatohepatitis , 2009, Hepatology.

[50]  S. Sanderson,et al.  Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial , 2009, Hepatology.

[51]  E. Niki Lipid peroxidation: physiological levels and dual biological effects. , 2009, Free radical biology & medicine.

[52]  H. Szajewska,et al.  Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review , 2009, Journal of pediatric gastroenterology and nutrition.

[53]  F. Nicoletti,et al.  Molecular mechanisms involved in NAFLD progression , 2009, Journal of Molecular Medicine.

[54]  M. Davies,et al.  What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. , 2009, Chemical research in toxicology.

[55]  R. Bataller,et al.  Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[56]  T. Okanoue,et al.  Role of hepatic iron in non‐alcoholic steatohepatitis , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[57]  Y. Takei,et al.  Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis , 2009, Cancer Epidemiology Biomarkers & Prevention.

[58]  Jun Yu,et al.  Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice , 2009, Scandinavian journal of gastroenterology.

[59]  I. Ichi,et al.  Effect of α-tocopherol on carbon tetrachloride intoxication in the rat liver , 2009, Archives of Toxicology.

[60]  N. Anderson,et al.  Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis , 2008, Pharmacological Reviews.

[61]  R. Murphy,et al.  Cholesterol, Reactive Oxygen Species, and the Formation of Biologically Active Mediators* , 2008, Journal of Biological Chemistry.

[62]  A. Cederbaum,et al.  CYP2E1 and oxidative liver injury by alcohol. , 2008, Free radical biology & medicine.

[63]  C. Wai,et al.  A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH) , 2008, Hepatology international.

[64]  P. Ravasco,et al.  Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet , 2008, Scandinavian journal of gastroenterology.

[65]  K. Jishage,et al.  Acceleration of lipid peroxidation in alpha-tocopherol transfer protein-knockout mice following the consumption of drinking water containing a radical initiator. , 2008, Journal of oleo science.

[66]  F. Guengerich Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[67]  R. Malekzadeh,et al.  Liver Histology Changes in Nonalcoholic Steatohepatitis after One Year of Treatment with Probucol , 2008, Digestive Diseases and Sciences.

[68]  M. Honda,et al.  Lipid‐induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet , 2007, Hepatology.

[69]  E. Niki Tocopherylquinone and tocopherylhydroquinone , 2007, Redox report : communications in free radical research.

[70]  L. N. Valenti,et al.  Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study , 2007, The American Journal of Gastroenterology.

[71]  T. Yoshikawa,et al.  Lipid peroxidation and lysosomal enzymes in D-galactosamine hepatitis and its protection by vitamin E , 2007, Gastroenterologia Japonica.

[72]  A. Federico,et al.  The Effect of a Silybin-Vitamin E-Phospholipid Complex on Nonalcoholic Fatty Liver Disease: A Pilot Study , 2007, Digestive Diseases and Sciences.

[73]  R. Rodrigo,et al.  Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. , 2006, Trends in molecular medicine.

[74]  J. Dufour,et al.  Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  T. Okanoue,et al.  Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[76]  Y. Jeon,et al.  A water extract of Artemisia capillaris prevents 2,2'-azobis(2-amidinopropane) dihydrochloride-induced liver damage in rats. , 2006, Journal of medicinal food.

[77]  F. Nicoletti,et al.  Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease , 2006, Gut.

[78]  I. Pikuleva CHOLESTEROL-METABOLIZING CYTOCHROMES P450 , 2006, Drug Metabolism and Disposition.

[79]  A. Cederbaum,et al.  Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1 , 2006, Hepatology.

[80]  R. Rodrigo,et al.  Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[81]  O. Erel,et al.  Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis , 2005, BMC gastroenterology.

[82]  K. Jishage,et al.  Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. , 2005, Toxicology and applied pharmacology.

[83]  M. Vidali,et al.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis , 2005, Gut.

[84]  M. Malaguarnera,et al.  Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. , 2005, Journal of hepatology.

[85]  B. Zilberstein,et al.  Lipid Peroxidation in Bariatric Candidates with Nonalcoholic Fatty Liver Disease (NAFLD) – Preliminary Findings , 2005, Obesity surgery.

[86]  E. Çakır,et al.  Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease , 2005, The American Journal of Gastroenterology.

[87]  P. Kar,et al.  Non-alcoholic steatohepatitis. , 2005, The Journal of the Association of Physicians of India.

[88]  S. Gawrieh,et al.  Oxidative Stress in Nonalcoholic Fatty Liver Disease: Pathogenesis and Antioxidant Therapies , 2004, Journal of Investigative Medicine.

[89]  N. Chalasani,et al.  Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis , 2004, American Journal of Gastroenterology.

[90]  J. Yodoi,et al.  Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[91]  L. Burgart,et al.  Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial , 2004, Hepatology.

[92]  R. Rodrigo,et al.  Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. , 2004, Clinical science.

[93]  A. Cederbaum,et al.  Oxidative stress, toxicology, and pharmacology of CYP2E1. , 2004, Annual review of pharmacology and toxicology.

[94]  M. Koruk,et al.  Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. , 2004, Annals of clinical and laboratory science.

[95]  P. Hayashi,et al.  Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis , 2003, American Journal of Gastroenterology.

[96]  C. McClain,et al.  Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E , 2003, Hepatology.

[97]  R. Malekzadeh,et al.  Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study. , 2003, Journal of hepatology.

[98]  J. Yodoi,et al.  Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. , 2003, Journal of hepatology.

[99]  Defeng Wu,et al.  Alcohol, Oxidative Stress, and Free Radical Damage , 2003, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[100]  S. Seki,et al.  In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. , 2002, Journal of hepatology.

[101]  N. Noguchi,et al.  The Specificity of Lipoxygenase-Catalyzed Lipid Peroxidation and the Effects of Radical- Scavenging Antioxidants , 2002, Biological chemistry.

[102]  V. Preedy,et al.  Effect of Chronic Ethanol Feeding on Oxysterols in Rat Liver , 2002, Free radical research.

[103]  A. Di Carlo,et al.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. , 2001, Journal of hepatology.

[104]  A. Terano,et al.  Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study , 2001, Alimentary pharmacology & therapeutics.

[105]  K. Lindor,et al.  Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study , 2001, American Journal of Gastroenterology.

[106]  S. Basu,et al.  Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats , 2001, European journal of nutrition.

[107]  A. Terano,et al.  Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. , 2001, Alimentary pharmacology & therapeutics.

[108]  L. Rovati,et al.  Efficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis , 2000, Arzneimittelforschung.

[109]  D. Russell,et al.  Oxysterol biosynthetic enzymes. , 2000, Biochimica et biophysica acta.

[110]  K. Itoh,et al.  Regulatory mechanisms of cellular response to oxidative stress. , 1999, Free radical research.

[111]  G. FitzGerald,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients , 1999 .

[112]  D. Russell,et al.  cDNA Cloning of Mouse and Human Cholesterol 25-Hydroxylases, Polytopic Membrane Proteins That Synthesize a Potent Oxysterol Regulator of Lipid Metabolism* , 1998, The Journal of Biological Chemistry.

[113]  H. Kühn,et al.  The Rabbit 15-Lipoxygenase Preferentially Oxygenates LDL Cholesterol Esters, and This Reaction Does Not Require Vitamin E* , 1998, The Journal of Biological Chemistry.

[114]  G. FitzGerald,et al.  Enhanced lipid peroxidation in hepatic cirrhosis. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[115]  C. Winterbourn,et al.  Hypochlorous acid-mediated modification of cholesterol and phospholipid: analysis of reaction products by gas chromatography-mass spectrometry. , 1993, Journal of lipid research.

[116]  H. Shimasaki,et al.  Free radical-induced liver injury. II. Effects of intraperitoneally administered 2,2'-azobis(2-amidinopropane) dihydrochloride on the fatty acid profiles of hepatic triacylglycerol and phospholipids. , 1991, Free radical research communications.

[117]  H. Shimasaki,et al.  Free radical-induced liver injury. I. Effects of dietary vitamin E deficiency on triacylglycerol level and its fatty acid profile in rat liver. , 1991, Free radical research communications.

[118]  E. Niki Free radical initiators as source of water- or lipid-soluble peroxyl radicals. , 1990, Methods in enzymology.

[119]  C. Lieber,et al.  Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding , 1989, Hepatology.

[120]  M. Takahashi,et al.  Oxidation of lipids. XV. Role of hydrophilic diarylamines as antioxidants in the oxidations of lipids and biological tissues. , 1988, Chemico-Biological Interactions.

[121]  T. Slater,et al.  Effects of α-Tocopherol on Carbon Tetrachloride Metabolism in Rat Liver Microsomes , 1987 .

[122]  J. Falck,et al.  Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450. , 1986, Biochemical and biophysical research communications.

[123]  E. Niki,et al.  Damage to biological tissues induced by radical initiator 2,2'-azobis(2-amidinopropane) dihydrochloride and its inhibition by chain-breaking antioxidants. , 1986, Journal of free radicals in biology & medicine.

[124]  G. Poli,et al.  Lipid peroxidation and molecular damage to polyunsaturated fatty acids in rat liver. Recognition of two classes of hydroperoxides formed under conditions in vivo. , 1986, Chemico-biological interactions.

[125]  T. Yoshikawa,et al.  Effects of vitamin E on D-galactosamine-induced or carbon tetrachloride-induced hepatotoxicity. , 1982, Digestion.

[126]  E. R. Davis,et al.  Spin-trapping of the trichloromethyl radical produced during enzymic NADPH oxidation in the presence of carbon tetrachloride or bromotrichloromethane. , 1978, Biochimica et biophysica acta.

[127]  I. Sipes,et al.  Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: role of cytochrome P-450. , 1977, Life sciences.

[128]  T. Slater Free-Radical Mechanisms in Tissue Injury , 1975 .

[129]  R. O. Recknagel Carbon tetrachloride hepatotoxicity. , 1967, Pharmacological reviews.

[130]  T. Slater Necrogenic Action of Carbon Tetrachloride in the Rat: A Speculative Mechanism Based on Activation , 1966, Nature.

[131]  T. Slater,et al.  Changes in liver nucleotide concentrations in experimental liver injury. 1. Carbon tetrachloride poisoning. , 1964, The Biochemical journal.

[132]  N. C. Davis The Influence of Diet upon the Liver Injury produced by Carbon Tetrachloride. , 1924, The Journal of medical research.